NM_006892.4:c.1674T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006892.4(DNMT3B):​c.1674T>C​(p.Tyr558Tyr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.505 in 1,613,114 control chromosomes in the GnomAD database, including 221,643 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 30442 hom., cov: 35)
Exomes 𝑓: 0.50 ( 191201 hom. )

Consequence

DNMT3B
NM_006892.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00005390
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: -2.83

Publications

29 publications found
Variant links:
Genes affected
DNMT3B (HGNC:2979): (DNA methyltransferase 3 beta) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined. [provided by RefSeq, May 2011]
DNMT3B Gene-Disease associations (from GenCC):
  • immunodeficiency-centromeric instability-facial anomalies syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • facioscapulohumeral muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency-centromeric instability-facial anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 20-32798643-T-C is Benign according to our data. Variant chr20-32798643-T-C is described in ClinVar as Benign. ClinVar VariationId is 338171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.83 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.971 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006892.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
NM_006892.4
MANE Select
c.1674T>Cp.Tyr558Tyr
splice_region synonymous
Exon 15 of 23NP_008823.1Q9UBC3-1
DNMT3B
NM_175850.3
c.1650T>Cp.Tyr550Tyr
splice_region synonymous
Exon 14 of 22NP_787046.1Q9UBC3-6
DNMT3B
NM_175848.2
c.1614T>Cp.Tyr538Tyr
splice_region synonymous
Exon 14 of 22NP_787044.1Q9UBC3-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
ENST00000328111.6
TSL:1 MANE Select
c.1674T>Cp.Tyr558Tyr
splice_region synonymous
Exon 15 of 23ENSP00000328547.2Q9UBC3-1
DNMT3B
ENST00000201963.3
TSL:1
c.1650T>Cp.Tyr550Tyr
splice_region synonymous
Exon 14 of 22ENSP00000201963.3Q9UBC3-6
DNMT3B
ENST00000348286.6
TSL:1
c.1614T>Cp.Tyr538Tyr
splice_region synonymous
Exon 14 of 20ENSP00000337764.2Q9UBC3-3

Frequencies

GnomAD3 genomes
AF:
0.600
AC:
91318
AN:
152130
Hom.:
30388
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.857
Gnomad AMI
AF:
0.591
Gnomad AMR
AF:
0.600
Gnomad ASJ
AF:
0.512
Gnomad EAS
AF:
0.993
Gnomad SAS
AF:
0.687
Gnomad FIN
AF:
0.452
Gnomad MID
AF:
0.399
Gnomad NFE
AF:
0.438
Gnomad OTH
AF:
0.550
GnomAD2 exomes
AF:
0.585
AC:
141045
AN:
241166
AF XY:
0.570
show subpopulations
Gnomad AFR exome
AF:
0.867
Gnomad AMR exome
AF:
0.730
Gnomad ASJ exome
AF:
0.508
Gnomad EAS exome
AF:
0.998
Gnomad FIN exome
AF:
0.455
Gnomad NFE exome
AF:
0.442
Gnomad OTH exome
AF:
0.520
GnomAD4 exome
AF:
0.495
AC:
723514
AN:
1460866
Hom.:
191201
Cov.:
60
AF XY:
0.497
AC XY:
361032
AN XY:
726684
show subpopulations
African (AFR)
AF:
0.866
AC:
28977
AN:
33474
American (AMR)
AF:
0.718
AC:
32051
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.511
AC:
13355
AN:
26128
East Asian (EAS)
AF:
0.999
AC:
39638
AN:
39694
South Asian (SAS)
AF:
0.655
AC:
56447
AN:
86214
European-Finnish (FIN)
AF:
0.456
AC:
24062
AN:
52788
Middle Eastern (MID)
AF:
0.459
AC:
2612
AN:
5694
European-Non Finnish (NFE)
AF:
0.444
AC:
494169
AN:
1111846
Other (OTH)
AF:
0.534
AC:
32203
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
20954
41908
62863
83817
104771
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15382
30764
46146
61528
76910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.601
AC:
91432
AN:
152248
Hom.:
30442
Cov.:
35
AF XY:
0.605
AC XY:
45034
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.857
AC:
35616
AN:
41566
American (AMR)
AF:
0.600
AC:
9190
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.512
AC:
1776
AN:
3470
East Asian (EAS)
AF:
0.993
AC:
5145
AN:
5180
South Asian (SAS)
AF:
0.686
AC:
3315
AN:
4834
European-Finnish (FIN)
AF:
0.452
AC:
4796
AN:
10600
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.438
AC:
29777
AN:
67972
Other (OTH)
AF:
0.550
AC:
1162
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1706
3412
5119
6825
8531
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.499
Hom.:
29991
Bravo
AF:
0.624
Asia WGS
AF:
0.842
AC:
2924
AN:
3478
EpiCase
AF:
0.430
EpiControl
AF:
0.426

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (2)
-
-
1
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency (1)
-
-
1
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.012
DANN
Benign
0.41
PhyloP100
-2.8
Mutation Taster
=53/47
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000054
dbscSNV1_RF
Benign
0.20
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2424922; hg19: chr20-31386449; COSMIC: COSV52414716; API